Health Observer Falkland Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Observer Falkland Islands.

Press releases published on November 4, 2026

an hour ago

Geron Corporation to Present Data Highlighting Clinical and Biological Activity of RYTELO® (imetelstat) at ASH 2026

Indeterminate GlobeNewswire

an hour ago

SELLAS Life Sciences to Present Positive Phase 2 Data Demonstrating Encouraging Response and Survival Outcomes with SLS009 Combination in High-Risk AML at ASH 2026

Indeterminate GlobeNewswire

an hour ago

Peer-Reviewed Scientific Journal Publishes U.S. Clinical Study Reporting Interim Results of 87.7% Accuracy for IR-MED’s PressureSafe™ Technology in Pressure-Injury Assessment

Indeterminate GlobeNewswire

an hour ago

TOMI Environmental Solutions, Inc. Announces Recurring Consumable Agreement with Global Eye Health Company

Indeterminate GlobeNewswire

an hour ago

OneMedNet Receives Mid Six-Figure Re-Order from Foundation Model Company Developing Radiology Models

Indeterminate GlobeNewswire

an hour ago

Eliminating Static Without Electricity - MEC Industries Introduces the Powerless ECO Ionizer

Indeterminate GlobeNewswire

an hour ago

Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

an hour ago

AltruBio to Host Virtual R&D Day on ALTB-268 and Ulcerative Colitis on November 11, 2026

Indeterminate GlobeNewswire

an hour ago

Clene Reports Third Quarter 2026 Financial Results and Recent Operating Highlights

Indeterminate GlobeNewswire

an hour ago

Intelligent Bio Solutions to Present at the Webull Biotech Webinar on November 12

Indeterminate GlobeNewswire

an hour ago

Aprea Therapeutics Announces Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

an hour ago

Medicus Pharma Announces Proposed SkinJect® Business Combination and Concurrent Financing

Indeterminate GlobeNewswire

an hour ago

Tango and Erasca Initiate Phase 1/2 Study of Oral PRMT5 Inhibitor Vopimetostat in Combination with Pan-RAS Molecular Glue ERAS-0015

Indeterminate GlobeNewswire

2 hours ago

CollPlant Announces Proposed Name Change to OptiPhi Computing Reflecting Expansion to Computing with Light

Indeterminate GlobeNewswire

2 hours ago

Intellia Therapeutics Completes Enrollment in Phase 3 MAGNITUDE-2 Trial of Nexiguran Ziclumeran (Nex-z) for Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy (ATTRv-PN)

Indeterminate GlobeNewswire

2 hours ago

Elicio Therapeutics to Host Virtual KOL Event on November 11, 2026: ELI-002 7P for Metastatic and Neoadjuvant PDAC

Indeterminate GlobeNewswire

2 hours ago

Rhythm Pharmaceuticals Announces NICE Guidance for IMCIVREE® (Setmelanotide) Updated to Include Adults Living with Bardet-Biedl Syndrome

Indeterminate GlobeNewswire

2 hours ago

Electra Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference in London

Indeterminate GlobeNewswire

2 hours ago

NewcelX Enters into Binding Term Sheet to Divest Legacy Mazindol Portfolio (CVR), Providing for Upfront Cash, Equity Ownership and Up to $55 Million in Potential Milestone Payments

Indeterminate GlobeNewswire

2 hours ago

Noom Names Leading Awe Researcher Dacher Keltner as Advisor, Announces New National Awe Day

Indeterminate GlobeNewswire